Godrej Consumer Products Limited

NSEI:GODREJCP Stock Report

Market Cap: ₹1.2t

Godrej Consumer Products Valuation

Is GODREJCP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GODREJCP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GODREJCP (₹1178.7) is trading above our estimate of fair value (₹413.39)

Significantly Below Fair Value: GODREJCP is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GODREJCP?

Key metric: As GODREJCP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GODREJCP. This is calculated by dividing GODREJCP's market cap by their current revenue.
What is GODREJCP's PS Ratio?
PS Ratio8.6x
Sales₹140.43b
Market Cap₹1.21t

Price to Sales Ratio vs Peers

How does GODREJCP's PS Ratio compare to its peers?

The above table shows the PS ratio for GODREJCP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average10.6x
DABUR Dabur India
7.2x8.8%₹900.7b
500830 Colgate-Palmolive (India)
12.2x9.2%₹742.7b
500459 Procter & Gamble Hygiene and Health Care
12.3x10.3%₹513.0b
507815 Gillette India
10.9xn/a₹302.6b
GODREJCP Godrej Consumer Products
8.6x10.2%₹1.2t

Price-To-Sales vs Peers: GODREJCP is good value based on its Price-To-Sales Ratio (8.6x) compared to the peer average (10.6x).

Price to Sales Ratio vs Industry

How does GODREJCP's PS Ratio compare vs other companies in the IN Personal Products Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
530689 Lykis
0.2xn/aUS$9.61m
524703 Sandu Pharmaceuticals
0.8xn/aUS$6.58m
542248 Deccan Health Care
0.8xn/aUS$6.55m
WALPAR Walpar Nutritions
0.6xn/aUS$4.73m
GODREJCP 8.6xIndustry Avg. 7.0xNo. of Companies5PS048121620+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GODREJCP is expensive based on its Price-To-Sales Ratio (8.6x) compared to the Indian Personal Products industry average (7x).

Price to Sales Ratio vs Fair Ratio

What is GODREJCP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GODREJCP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio8.6x
Fair PS Ratio10x

Price-To-Sales vs Fair Ratio: GODREJCP is good value based on its Price-To-Sales Ratio (8.6x) compared to the estimated Fair Price-To-Sales Ratio (10x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GODREJCP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹1,178.70
₹1,456.97
+23.6%
8.7%₹1,680.00₹1,035.00n/a36
Nov ’25₹1,275.10
₹1,457.17
+14.3%
8.8%₹1,680.00₹1,035.00n/a35
Oct ’25₹1,388.25
₹1,530.69
+10.3%
9.1%₹1,715.00₹1,020.00n/a35
Sep ’25₹1,481.20
₹1,535.94
+3.7%
9.2%₹1,715.00₹1,020.00n/a35
Aug ’25₹1,470.25
₹1,435.91
-2.3%
8.3%₹1,652.00₹1,079.00n/a35
Jul ’25₹1,398.05
₹1,425.46
+2.0%
7.9%₹1,652.00₹1,079.00n/a35
Jun ’25₹1,270.35
₹1,400.89
+10.3%
8.2%₹1,580.00₹1,079.00n/a36
May ’25₹1,219.50
₹1,314.00
+7.7%
9.5%₹1,520.00₹1,025.00n/a35
Apr ’25₹1,228.35
₹1,301.12
+5.9%
9.9%₹1,520.00₹996.00n/a34
Mar ’25₹1,267.45
₹1,287.41
+1.6%
9.5%₹1,520.00₹996.00n/a34
Feb ’25₹1,254.55
₹1,260.85
+0.5%
8.8%₹1,520.00₹996.00n/a34
Jan ’25₹1,144.80
₹1,148.82
+0.4%
7.2%₹1,350.00₹930.00n/a34
Dec ’24₹1,025.40
₹1,130.59
+10.3%
6.5%₹1,250.00₹930.00n/a34
Nov ’24₹974.65
₹1,131.88
+16.1%
6.8%₹1,315.00₹930.00₹1,275.1033
Oct ’24₹991.60
₹1,143.94
+15.4%
6.7%₹1,315.00₹970.00₹1,388.2532
Sep ’24₹1,005.35
₹1,140.33
+13.4%
6.9%₹1,315.00₹970.00₹1,481.2033
Aug ’24₹1,020.45
₹1,121.76
+9.9%
7.3%₹1,315.00₹975.00₹1,470.2533
Jul ’24₹1,081.00
₹1,098.06
+1.6%
7.1%₹1,225.00₹908.00₹1,398.0532
Jun ’24₹1,054.20
₹1,086.66
+3.1%
7.0%₹1,200.00₹908.00₹1,270.3532
May ’24₹907.50
₹1,041.44
+14.8%
7.6%₹1,200.00₹888.00₹1,219.5032
Apr ’24₹968.15
₹1,037.32
+7.1%
7.5%₹1,200.00₹880.00₹1,228.3531
Mar ’24₹912.05
₹1,022.86
+12.1%
7.5%₹1,152.00₹860.00₹1,267.4535
Feb ’24₹929.70
₹1,019.54
+9.7%
7.6%₹1,175.00₹860.00₹1,254.5535
Jan ’24₹874.05
₹961.23
+10.0%
9.0%₹1,175.00₹662.00₹1,144.8035
Dec ’23₹877.25
₹956.80
+9.1%
9.0%₹1,175.00₹662.00₹1,025.4035
Nov ’23₹838.40
₹971.45
+15.9%
9.4%₹1,175.00₹662.00₹974.6533

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

DABUR

₹508.20

7D

-0.5%

1Y

-6.1%

Jyothy Labs

₹148.6b

Engages in the manufacture and marketing of fabric care, dishwashing, personal care, and household insecticides products in India and internationally.

JYOTHYLAB

₹404.75

7D

-7.2%

1Y

-8.3%

Dabur India

₹900.7b

Operates as a fast-moving consumer goods company worldwide.

500096

₹508.25

7D

-0.5%

1Y

-6.0%